Giant-cell arteritis associated with myelodysplastic syndrome: French multicenter case control study and literature review.

[1]  P. Fenaux,et al.  Autoimmune manifestations associated with myelodysplastic syndromes , 2018, Annals of Hematology.

[2]  T. Higuchi,et al.  Simultaneous Presentation of Giant Cell Arteritis and Myelodysplastic Syndrome in an Elderly Japanese Man , 2018, Internal medicine.

[3]  M. McCormack,et al.  A Rare Case of Paraneoplastic Aortitis Associated with Chronic Myelomonocytic Leukemia , 2017, Case reports in hematology.

[4]  M. Vicaretti,et al.  Migratory large vessel vasculitis preceding acute myeloid leukemia: a case report , 2017, Journal of Medical Case Reports.

[5]  A. Aouba,et al.  Giant-cell arteritis without cranial manifestations , 2016, Medicine.

[6]  O. Decaux,et al.  Efficacy of Azacitidine in Autoimmune and Inflammatory Disorders associated with Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia Running title : Azacitidine in autoimmune disorders associated with MDS / CMML , 2018 .

[7]  J. Piette,et al.  Systemic inflammatory and autoimmune manifestations associated with myelodysplastic syndromes and chronic myelomonocytic leukaemia: a French multicentre retrospective study. , 2016, Rheumatology.

[8]  T. Itoh,et al.  Acute Myeloid Leukemia Complicated by Giant Cell Arteritis. , 2016, Internal medicine.

[9]  K. Imajo,et al.  [Successful treatment with azacitidine for myelodysplastic syndrome with large vessel vasculitis]. , 2015, [Rinsho ketsueki] The Japanese journal of clinical hematology.

[10]  P. Fenaux,et al.  Myelodysplastic syndromes , 2014, The Lancet.

[11]  H. Yokozaki,et al.  Recurrence of abdominal large‐vessel vasculitis and development of severe Sweet syndrome after a single cycle of 5‐azacytidine in a patient with myelodysplastic syndrome , 2014, European journal of haematology.

[12]  H. Makino,et al.  Large vessel vasculitis with myelodysplastic syndrome. , 2014, Internal medicine.

[13]  S. Fleming,et al.  Paraneoplastic large vessel arteritis complicating myelodysplastic syndrome , 2012, Leukemia & lymphoma.

[14]  Sophie Park,et al.  The autoimmune manifestations associated with myelodysplastic syndrome respond to 5‐azacytidine: a report on three cases , 2011, British journal of haematology.

[15]  M. Steurer,et al.  Large‐vessel arteritis and myelodysplastic syndrome: report of two cases , 2004, European journal of haematology.

[16]  T. Sugita,et al.  Suppression of fibroblast activity by an inhibitor of dipeptidyl peptidase IV: a possible therapeutic strategy for rheumatoid arthritis. , 2003, Clinical and Experimental Rheumatology.

[17]  H. Milionis,et al.  Temporal arteritis masquerading as chronic myelomonocytic leukemia. , 2003, Clinical and experimental rheumatology.

[18]  G. Espinosa,et al.  Myelodysplastic and Myeloproliferative Syndromes Associated with Giant Cell Arteritis and Polymyalgia Rheumatica: A Coincidental Coexistence or a Causal Relationship? , 2002, Clinical Rheumatology.

[19]  A. Mega,et al.  Aortitis as a manifestation of myelodysplastic syndrome , 2001, Postgraduate medical journal.

[20]  B. Johansson,et al.  Immune‐mediated complications in patients with myelodysplastic syndromes – clinical and cytogenetic features , 1995, European journal of haematology.

[21]  R. Bennett,et al.  An association of polymyalgia rheumatica with myelodysplastic syndromes. , 1994, The Journal of rheumatology.

[22]  L. Vaillant,et al.  [Horton's disease and myelodysplastic syndrome associated with unusual cutaneous manifestations]. , 1992, Annales de dermatologie et de venereologie.